Lawsuit Overview
An investor in Cephalon, Inc. (NASDAQ:CEPH) filed a lawsuit in effort to force the board of directors of Cephalon Inc. to engage with Valeant Pharmaceuticals Intl, Inc. to take over Cephalon, Inc. According to the complaint the plaintiff alleges the defendants breached their fiduciary duty by failing to put even a minimum effort to evaluate the offer or engage in negotiations to maxi...
You must register (for free) or login to view the entire case.